ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

4 links0 made here, not in the record8 judgments2 judges (the rules as one: Rule based)8 record changes seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.gov
Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT05773274Comparing Retreatment of177Lu-DOTATATE PRRT Versusthe Usual Treatment inPatients With MetastaticUnresectableGastroenteropancreaticNeuroendocrine Tumors, NETNational Cancer Institute (NCIPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 1 · ClinicalTrials.gov record · Version of 2026-10-01Oct 2 · ClinicalTrials.gov record · Version of 2026-10-02Oct 5 · ClinicalTrials.gov record · Version of 2026-10-05Oct 8 · ClinicalTrials.gov record · Version of 2026-10-08Oct 16 · ClinicalTrials.gov record · Version of 2026-10-16Oct 28 · ClinicalTrials.gov record · Version of 2026-10-28Nov 3 · ClinicalTrials.gov record · Version of 2026-11-03Nov 12 · ClinicalTrials.gov record · Version of 2026-11-12Version of 2026-11-12DRUGSCabozantinibIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorEverolimusIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorLutetium Lu 177 dotatateIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedSunitinibIntervention entry›Nov 3 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparator

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Cabozantinib

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Cabozantinib”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Comparator
Comparator · 2

All judgments on this study

WhenLinkJudgeDecisionState
Oct 1The record itselfClinicalTrials.gov recordVersion of 2026-10-01Record change
Oct 2The record itselfClinicalTrials.gov recordVersion of 2026-10-02Record change
Oct 5The record itselfClinicalTrials.gov recordVersion of 2026-10-05Record change
Oct 8The record itselfClinicalTrials.gov recordVersion of 2026-10-08Record change
Oct 16The record itselfClinicalTrials.gov recordVersion of 2026-10-16Record change
Oct 28The record itselfClinicalTrials.gov recordVersion of 2026-10-28Record change
Nov 3CabozantinibClaude Opus 5.5ComparatorCurrent
Nov 3EverolimusClaude Opus 5.5ComparatorCurrent
Nov 3Lutetium Lu 177 dotatateClaude Opus 5.5TestedCurrent
Nov 3SunitinibClaude Opus 5.5ComparatorCurrent
Nov 3The record itselfClinicalTrials.gov recordVersion of 2026-11-03Record change
Nov 12The record itselfClinicalTrials.gov recordVersion of 2026-11-12Record change
Nov 18CabozantinibRule based · role ruleComparatorAgrees
Nov 18EverolimusRule based · role ruleComparatorAgrees
Nov 18Lutetium Lu 177 dotatateRule based · role ruleTestedAgrees
Nov 18SunitinibRule based · role ruleComparatorAgrees

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.